CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
;
SarahMaguire;
AnnaMorra;
Pooja Middha Kapoor ;
KatarzynaTomczyk;
Michael EJones;
Minouk JSchoemaker;
Clare Gilham ;
Manjeet KBolla;
QinWang;
+142 more...
Joe Dennis ;
Thomas UAhearn;
Irene LAndrulis;
HodaAnton-Culver;
Natalia NAntonenkova;
VolkerArndt;
Kristan JAronson;
AnnelieAugustinsson;
CarolineBaynes;
Laura E BeaneFreeman;
Matthias WBeckmann;
JavierBenitez;
MarinaBermisheva;
CarlBlomqvist;
BramBoeckx;
Natalia VBogdanova;
Stig EBojesen;
HiltrudBrauch;
Hermann Brenner ;
BarbaraBurwinkel;
DanieleCampa;
Federico Canzian ;
Jose ECastelao;
Stephen JChanock;
GeorgiaChenevix-Trench;
Christine LClarke;
NBCS Collaborators;
Don MConroy;
Fergus JCouch;
Angela Cox ;
Simon SCross;
KamilaCzene;
ThiloDörk;
A HeatherEliassen;
ChristophEngel;
D GarethEvans;
Peter A Fasching ;
JonineFigueroa;
GiuseppeFloris;
HenrikFlyger;
ManuelaGago-Dominguez;
Susan MGapstur;
MontserratGarcía-Closas;
Mia MGaudet;
Graham GGiles;
Mark SGoldberg;
AnnaGonzález-Neira;
AOCS Group;
PascalGuénel;
EricHahnen;
Christopher AHaiman;
NiclasHåkansson;
PerHall;
UteHamann;
Patricia AHarrington;
Steven N Hart ;
Maartje JHooning;
John LHopper;
AnthonyHowell;
David JHunter;
ABCTB Investigators;
kConFab Investigators;
AgnesJager;
Anna Jakubowska ;
Esther MJohn;
RudolfKaaks;
RenskeKeeman;
ElzaKhusnutdinova;
Cari MKitahara;
Veli-MattiKosma;
StellaKoutros;
PeterKraft;
Vessela NKristensen;
Allison W Kurian ;
DietherLambrechts;
LoicLe Marchand;
MarthaLinet;
JanLubiński;
ArtoMannermaa;
SiranoushManoukian;
SaraMargolin;
John WMMartens;
DimitriosMavroudis;
RebeccaMayes;
AlfonsMeindl;
Roger LMilne;
Susan LNeuhausen;
HeliNevanlinna;
William GNewman;
Sune FNielsen;
Børge GNordestgaard;
NadiaObi;
Andrew FOlshan;
Janet EOlson;
HåkanOlsson;
EsterOrban;
Tjoung-WonPark-Simon;
Paolo Peterlongo ;
DijanaPlaseska-Karanfilska;
KatriPylkäs;
GadRennert;
Hedy SRennert;
Kathryn JRuddy;
EmmanouilSaloustros;
Dale PSandler;
Elinor J Sawyer ;
Rita KSchmutzler;
ChristopherScott;
Xiao-OuShu;
JacquesSimard;
SnezhanaSmichkoska;
ChristofSohn;
Melissa CSouthey;
John JSpinelli;
JenniferStone;
Rulla MTamimi;
Jack ATaylor;
Rob AEMTollenaar;
Ian Tomlinson ;
Melissa ATroester;
Thérèse Truong ;
Celine MVachon;
Elke Mvan Veen;
Sophia SWang;
Clarice RWeinberg;
CamillaWendt;
HansWildiers;
RobertWinqvist;
AlicjaWolk;
WeiZheng;
ArgyriosZiogas;
Alison MDunning;
Paul DP Pharoah ;
Douglas FEaston;
A ForbesHowie;
Julian Peto ;
Isabel Dos-Santos-Silva ;
Anthony JSwerdlow;
JennyChang-Claude;
Marjanka KSchmidt;
NickOrr;
OliviaFletcher;
(2021)
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
British journal of cancer, 124 (4).
pp. 842-854.
ISSN 0007-0920
DOI: 10.1038/s41416-020-01185-w
BACKGROUND: Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that are associated with urinary sex-hormone levels and breast cancer risk. METHODS: We carried out a genome-wide association study of urinary oestrone-3-glucuronide and pregnanediol-3-glucuronide levels in 560 premenopausal women, with additional analysis of progesterone levels in 298 premenopausal women. To test for the association with breast cancer risk, we carried out follow-up genotyping in 90,916 cases and 89,893 controls from the Breast Cancer Association Consortium. All women were of European ancestry. RESULTS: For pregnanediol-3-glucuronide, there were no genome-wide significant associations; for oestrone-3-glucuronide, we identified a single peak mapping to the CYP3A locus, annotated by rs45446698. The minor rs45446698-C allele was associated with lower oestrone-3-glucuronide (-49.2%, 95% CI -56.1% to -41.1%, P = 3.1 × 10-18); in follow-up analyses, rs45446698-C was also associated with lower progesterone (-26.7%, 95% CI -39.4% to -11.6%, P = 0.001) and reduced risk of oestrogen and progesterone receptor-positive breast cancer (OR = 0.86, 95% CI 0.82-0.91, P = 6.9 × 10-8). CONCLUSIONS: The CYP3A7*1C allele is associated with reduced risk of hormone receptor-positive breast cancer possibly mediated via an effect on the metabolism of endogenous sex hormones in premenopausal women.
-
picture_as_pdf - s41416-020-01185-w.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
Find work from this publication: